Invariant natural killer T cells infiltrate intestinal allografts undergoing acute cellular rejection

Transplant International

Volumn 25, Issue 5, 2012, Pages 537-544

  Tsuruyama, Tatsuaki ^a   Fujimoto, Yasuhiro ^a   Yonekawa, Yukihide ^a   Miyao, Masashi ^a   Onodera, Hisashi ^b   Uemoto, Shinji ^a   Haga, Hironori ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

Author keywords

acute cellular rejection; intestinal transplantation; natural killer T cell

Indexed keywords

INTERLEUKIN 4; INTERLEUKIN 5;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CYTOKINE RELEASE; DISEASE COURSE; EOSINOPHILIC ENTERITIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INTESTINE ALLOGRAFT ACUTE CELLULAR REJECTION; LYMPHOCYTIC INFILTRATION; MALE; MORPHOMETRICS; NATURAL KILLER T CELL; NEWBORN; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN CONTENT; SCHOOL CHILD; TH2 CELL;

ACUTE DISEASE; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; HUMANS; INFANT; INTERLEUKIN-4; INTERLEUKIN-5; INTESTINAL MUCOSA; INTESTINE, SMALL; LIVING DONORS; MALE; MIDDLE AGED; NATURAL KILLER T-CELLS; YOUNG ADULT;

EID: 84859729347     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2012.01450.x     Document Type: Article

References (31)

1. Pirenne J, Hoffman I, Miserez M, et al. Selection criteria and outcome of patients referred to intestinal transplantation: an European center experience. Transplant Proc 2006; 38: 1671.
2. Reyes J,. Intestinal transplantation for children with short bowel syndrome. Semin Pediatr Surg 2001; 10: 99.
3. Vanderhoof JA,. Short bowel syndrome in children and small intestinal transplantation. Pediatr Clin North Am 1996; 43: 533.
4. Avitzur Y, Grant D,. Intestine transplantation in children: update 2010. Pediatr Clin North Am 2010; 57: 415. Table of contents.
5. Goulet O, Sauvat F,. Short bowel syndrome and intestinal transplantation in children. Curr Opin Clin Nutr Metab Care 2006; 9: 304.
6. Wu T, Abu-Elmagd K, Bond G, Nalesnik MA, Randhawa P, Demetris AJ,. A schema for histologic grading of small intestine allograft acute rejection. Transplantation 2003; 75: 1241.
7. Lee RG, Nakamura K, Tsamandas AC, et al. Pathology of human intestinal transplantation. Gastroenterology 1996; 110: 1820.
8. Asaoka T, Island ER, Tryphonopoulos P, et al. Characteristic immune, apoptosis and inflammatory gene profiles associated with intestinal acute cellular rejection in formalin-fixed paraffin-embedded mucosal biopsies. Transpl Int 2011; 24: 697.
9. Taniguchi M, Harada M, Kojo S, Nakayama T, Wakao H,. The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu Rev Immunol 2003; 21: 483.
10. Ruiz P, Bagni A, Brown R, et al. Histological criteria for the identification of acute cellular rejection in human small bowel allografts: results of the pathology workshop at the VIII International Small Bowel Transplant Symposium. Transplant Proc 2004; 36: 335.
11. Exley M, Porcelli S, Furman M, Garcia J, Balk S,. CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant V alpha 24 J alpha Q T cell receptor alpha chains. J Exp Med 1998; 188: 867.
12. Dellabona P, Padovan E, Casorati G, Brockhaus M, Lanzavecchia A,. An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells. J Exp Med 1994; 180: 1171.
13. Spada FM, Koezuka Y, Porcelli SA,. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J Exp Med 1998; 188: 1529.
14. Onzuka T, Tomita Y, Shimizu I, et al. Role of the cytokine profiles produced by invariant natural killer T cells in the initial phase of cyclophosphamide-induced tolerance. Transplantation 2008; 86: 1301.
15. Tachibana T, Onodera H, Tsuruyama T, et al. Increased intratumor Valpha24-positive natural killer T cells: a prognostic factor for primary colorectal carcinomas. Clin Cancer Res 2005; 11: 7322.
16. O'Keeffe J, Doherty DG, Kenna T, et al. Diverse populations of T cells with NK cell receptors accumulate in the human intestine in health and in colorectal cancer. Eur J Immunol 2004; 34: 2110.
17. Fujimoto Y, Uemoto S, Inomata Y, et al. Small bowel transplantation using grafts from living-related donors. Two case reports. Transpl Int 2000; 13 (Suppl. 1): S179.
18. Friel J, Grande J, Hetzner D,. Practical Guide to Image Analysis. ASM International: Warrensville Hts., OH, 2000: 157 pp.
19. Oishi Y, Sakamoto A, Kurasawa K, et al. CD4-CD8- T cells bearing invariant Valpha24JalphaQ TCR alpha-chain are decreased in patients with atopic diseases. Clin Exp Immunol 2000; 119: 404.
20. Heijmans-Antonissen C, Wesseldijk F, Munnikes RJ, et al. Multiplex bead array assay for detection of 25 soluble cytokines in blister fluid of patients with complex regional pain syndrome type 1. Mediators Inflamm 2006; 2006: 28398.
21. Paul WE, Seder RA,. Lymphocyte responses and cytokines. Cell 1994; 76: 241.
22. Karczewski J, Karczewski M, Glyda M, Wiktorowicz K,. Role of TH1/TH2 cytokines in kidney allograft rejection. Transplant Proc 2008; 40: 3390.
23. Ikehara Y, Yasunami Y, Kodama S, et al. CD4(+) Valpha14 natural killer T cells are essential for acceptance of rat islet xenografts in mice. J Clin Invest 2000; 105: 1761.
24. Hong S, Wilson MT, Serizawa I, et al. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med 2001; 7: 1052.
25. Seino KI, Fukao K, Muramoto K, et al. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc Natl Acad Sci U S A 2001; 98: 2577.
26. Neurath MF, Finotto S, Glimcher LH,. The role of Th1/Th2 polarization in mucosal immunity. Nat Med 2002; 8: 567.
27. Kugathasan S, Saubermann LJ, Smith L, et al. Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease. Gut 2007; 56: 1696.
28. Heller F, Fuss IJ, Nieuwenhuis EE, Blumberg RS, Strober W,. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 2002; 17: 629.
29. Fuss IJ, Heller F, Boirivant M, et al. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest 2004; 113: 1490.
30. van Dieren JM, van der Woude CJ, Kuipers EJ, et al. Roles of CD1d-restricted NKT cells in the intestine. Inflamm Bowel Dis 2007; 13: 1146.
31. Kim CH, Johnston B, Butcher EC,. Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity. Blood 2002; 100: 11.